Advertisement
Aurora Cannabis Inc.

Aurora Cannabis Inc. Fundamental Analysis

ACB.TOTSX
HealthcareDrug Manufacturers - Specialty & Generic
$4.22
$0.07(1.69%)
Canadian Market is Open · 09:44
Advertisement

Aurora Cannabis Inc. Fundamental Analysis

Aurora Cannabis Inc. (ACB.TO) shows weak financial fundamentals with a PE ratio of -6.24, profit margin of -12.13%, and ROE of -7.25%. The company generates $0.3B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position67.91%
PEG Ratio-0.04
Current Ratio5.94

Areas of Concern

ROE-7.25%
Operating Margin-23.04%
We analyze ACB.TO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 15.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
15.3/100

We analyze ACB.TO's fundamental strength across five key dimensions:

Efficiency Score

Weak

ACB.TO struggles to generate sufficient returns from assets.

ROA > 10%
-6.42%

Valuation Score

Excellent

ACB.TO trades at attractive valuation levels.

PE < 25
-6.24
PEG Ratio < 2
-0.04

Growth Score

Weak

ACB.TO faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ACB.TO maintains a strong and stable balance sheet.

Debt/Equity < 1
0.05
Current Ratio > 1
5.94

Profitability Score

Weak

ACB.TO struggles to sustain strong margins.

ROE > 15%
-724.51%
Net Margin ≥ 15%
-12.13%
Positive Free Cash Flow
No

Key Financial Metrics

Is ACB.TO Expensive or Cheap?

P/E Ratio

ACB.TO trades at -6.24 times earnings. This suggests potential undervaluation.

-6.24

PEG Ratio

When adjusting for growth, ACB.TO's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values Aurora Cannabis Inc. at 0.47 times its book value. This may indicate undervaluation.

0.47

EV/EBITDA

Enterprise value stands at 35.48 times EBITDA. This signals the market has high growth expectations.

35.48

How Well Does ACB.TO Make Money?

Net Profit Margin

For every $100 in sales, Aurora Cannabis Inc. keeps $-12.13 as profit after all expenses.

-12.13%

Operating Margin

Core operations generate -23.04 in profit for every $100 in revenue, before interest and taxes.

-23.04%

ROE

Management delivers $-7.25 in profit for every $100 of shareholder equity.

-7.25%

ROA

Aurora Cannabis Inc. generates $-6.42 in profit for every $100 in assets, demonstrating efficient asset deployment.

-6.42%

Following the Money - Real Cash Generation

Operating Cash Flow

Aurora Cannabis Inc. generates limited operating cash flow of $-14.56M, signaling weaker underlying cash strength.

$-14.56M

Free Cash Flow

Aurora Cannabis Inc. generates weak or negative free cash flow of $-38.86M, restricting financial flexibility.

$-38.86M

FCF Per Share

Each share generates $-0.63 in free cash annually.

$-0.63

FCF Yield

ACB.TO converts -13.91% of its market value into free cash.

-13.91%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-6.24

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.47

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.82

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.05

vs 25 benchmark

Current Ratio

Current assets to current liabilities

5.94

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.07

vs 25 benchmark

ROA

Return on assets percentage

-0.06

vs 25 benchmark

ROCE

Return on capital employed

-0.14

vs 25 benchmark

How ACB.TO Stacks Against Its Sector Peers

MetricACB.TO ValueSector AveragePerformance
P/E Ratio-6.2433.74 Better (Cheaper)
ROE-7.25%404.00% Weak
Net Margin-12.13%-40219.00% (disorted) Weak
Debt/Equity0.050.81 Strong (Low Leverage)
Current Ratio5.945.53 Strong Liquidity
ROA-6.42%-281.00% (disorted) Weak

ACB.TO outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aurora Cannabis Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ